BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18678398)

  • 1. Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.
    Neal M; Crowther M; Douketis J; Verhovsek M; Stidley C; Garcia D
    Thromb Res; 2008; 122(6):864-6. PubMed ID: 18678398
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 3. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
    Garcia DA; Regan S; Crowther M; Hylek EM
    J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical management of coagulopathy associated with warfarin.
    Garcia D; Crowther MA; Ageno W
    BMJ; 2010 Apr; 340():c1813. PubMed ID: 20404060
    [No Abstract]   [Full Text] [Related]  

  • 5. Urgent warfarin reversal: know your options.
    Pendergrast J
    Can J Anaesth; 2010 May; 57(5):395-401. PubMed ID: 20177848
    [No Abstract]   [Full Text] [Related]  

  • 6. Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.
    Dickerson RN
    Nutrition; 2008 Oct; 24(10):1048-52. PubMed ID: 18602249
    [No Abstract]   [Full Text] [Related]  

  • 7. What to do when warfarin therapy goes too far.
    Prasad S; Wootten MR; Kulinski N; Chapman SA
    J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing 1 mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves.
    Ageno W; Garcia D; Silingardi M; Galli M; Crowther M
    J Am Coll Cardiol; 2005 Aug; 46(4):732-3. PubMed ID: 16098445
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of warfarin-associated coagulopathy in patients with acute gastrointestinal bleeding: a cross-sectional physician survey of current practice.
    Radaelli F; Paggi S; Terruzzi V; Meucci G; Manes G; Saibeni S; Soncini M; Masci E; Conte D
    Dig Liver Dis; 2011 Jun; 43(6):444-7. PubMed ID: 21168374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 12. [Practical treatment of warfarin associated coagulation disorder].
    Garcia D; Crowther MA; Ageno W
    Praxis (Bern 1994); 2010 Dec; 99(25):1569-73. PubMed ID: 21157725
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal reversal of vitamin K antagonists.
    Schulman S
    Thromb Res; 2007; 119(1):15-6. PubMed ID: 16310838
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
    Garcia D; Ageno W; Bussey H; Eikelboom J; Margaglione M; Marongiu F; Moia M; Palareti G; Pengo V; Poli D; Schulman S; Witt D; Wittkowksy A; Crowther M
    Am J Hematol; 2009 Sep; 84(9):579-83. PubMed ID: 19610022
    [No Abstract]   [Full Text] [Related]  

  • 16. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing excessive warfarin anticoagulation.
    Bussey HI
    Ann Intern Med; 2001 Sep; 135(6):460-2. PubMed ID: 11560459
    [No Abstract]   [Full Text] [Related]  

  • 18. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
    Aiyagari V; Testai FD
    Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring warfarin therapy.
    Beanland DR; Dorsey DA
    Am Fam Physician; 1999 Sep; 60(3):764, 766. PubMed ID: 10498107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current issues in the initial phase of warfarin therapy].
    Squizzato A; Steidl L; Ageno W
    Recenti Prog Med; 2005 Dec; 96(12):612-5. PubMed ID: 16496748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.